{
  "ticker": "JNJ",
  "target_date": "2025-02-10",
  "actual_date": "2025-02-10",
  "collected_at": "2025-12-08T11:23:06.182976",
  "price": {
    "open": 149.05,
    "high": 149.78,
    "low": 147.77,
    "close": 149.6588592529297,
    "volume": 6936200,
    "change_1d_pct": 0.73,
    "change_7d_pct": 0.9,
    "change_30d_pct": 5.75
  },
  "technicals": {
    "rsi_14": 63.83,
    "sma_20": 145.36,
    "sma_50": 143.82,
    "macd": 1.937,
    "macd_signal": 1.447,
    "macd_histogram": 0.49,
    "bb_upper": 152.32,
    "bb_lower": 138.41,
    "price_vs_sma20_pct": 2.96,
    "price_vs_sma50_pct": 4.06,
    "volume_ratio": 0.73
  },
  "fundamentals": {
    "market_cap": 488918253568,
    "pe_ratio": 19.587837,
    "forward_pe": 19.144339,
    "price_to_book": 6.159286,
    "price_to_sales": 5.305736,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.35,
    "pct_from_52w_low": 44.25
  },
  "macro": {
    "spy": {
      "price": 599.6,
      "change_1d_pct": 0.68,
      "change_7d_pct": 0.5
    },
    "vix": {
      "level": 15.81,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.49
    },
    "dollar_index": {
      "level": 108.32
    },
    "gold": {
      "price": 2914.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Fidelity Strategic Dividend & Income Fund Q4 2024 Review",
      "source": "SeekingAlpha",
      "datetime": 1739171880,
      "summary": "Our investment approach aims to offer a well-diversified strategy with the potential to deliver strong income regardless of the interest-rate environment. Read more here.",
      "url": "https://finnhub.io/api/news?id=65d7b3501135eaa1771350aa8ed5f26a1303b5b2c0fc5741b9cbb1ac3a9c5162"
    },
    {
      "headline": "Fidelity Balanced Fund Q4 2024 Review",
      "source": "SeekingAlpha",
      "datetime": 1739166420,
      "summary": "For the fourth quarter of 2024, the fund's Retail Class shares gained 0.59%, topping the 0.21% advance of the Fidelity Balanced Hybrid Composite Index.",
      "url": "https://finnhub.io/api/news?id=7c34e5ec1886892b43a7d8b9af347c4f7ece1218b33a8431c1e9ba0b668ed284"
    },
    {
      "headline": "Tweedy, Browne Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739149200,
      "summary": "Setting aside a rather brief hiccup mid-quarter, the bull market in global equities continued in force during Q4 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=e02945fdabaed045becd514285a918f53131f289764f0daac05ac0a6e35faaf7"
    },
    {
      "headline": "Kenvue: An Intriguing Turnaround",
      "source": "SeekingAlpha",
      "datetime": 1739145811,
      "summary": "Kenvue's improvements in marketing and management could drive future growth. Read why there is potential for a turnaround for KVUE stock.",
      "url": "https://finnhub.io/api/news?id=e0ef08b5d0cc280abd3b26b8dec3df2fd038150bdd549af9f515ebfdc226fc53"
    },
    {
      "headline": "One 'Safer' Buy In 10 February Dogs Of The Dow",
      "source": "SeekingAlpha",
      "datetime": 1739001261,
      "summary": "Verizon's dividend yield and Merck\u00e2\u0080\u0099s growth lead the Dow Dogs. Read why they\u00e2\u0080\u0099re set for solid returns, with other top picks closely following in February 2026.",
      "url": "https://finnhub.io/api/news?id=14b4128129dde93c0054cd30e448c400a14d653d5137e8f85fb50551b472f598"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-01-22",
      "description": "jnj-20250122.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000003/jnj-20250122.htm"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}